Publications by authors named "Ralph R Minter"

Claim this Profile
T
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes.
Jonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, Katelyn Cassidy, Fiona Pachl, Ralph R Minter

Commun Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region.
Kalliopi Skamaki, Stephane Emond, Matthieu Chodorge, John Andrews, D Gareth Rees, Ralph R Minter

Proc Natl Acad Sci U S A· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency.
Christina Schindler, Andie Collinson, Carl Matthews, Amy Pointon, Lesley Jenkinson, Ralph R Minter

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, Blagoje Soskic, Shereen Sabbah, Ralph R Minter

J Immunol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic screening-the fast track to novel antibody discovery.
Ralph R Minter, Alan M Sandercock, Steven J Rust

Drug Discov Today Technol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, Blagoje Soskic, Shereen Sabbah, Ralph R Minter

J Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Shorter Route to Antibody Binders via Quantitative in vitro Bead-Display Screening and Consensus Analysis.
Sylwia A Mankowska, Pietro Gatti-Lafranconi, Matthieu Chodorge, Sudharsan Sridharan, Ralph R Minter

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic screening: the future of antibody discovery.
Andrea L Gonzalez-Munoz, Ralph R Minter, Steven J Rust

Drug Discov Today· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.
Carole Urbach, Nathaniel C Gordon, Ian Strickland, David Lowne, Cathy Joberty-Candotti, Ralph R Minter

Chem Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering therapeutic proteins for cell entry: the natural approach.
Sandrine Guillard, Ralph R Minter, Ronald H Jackson

Trends Biotechnol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.
Claire L Dobson, Sarah Main, Philip Newton, Matthieu Chodorge, Karen Cadwallader, Ralph R Minter

MAbs· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing phage and ribosome display for antibody optimisation.
Patrick Dufner, Lutz Jermutus, Ralph R Minter

Trends Biotechnol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing a protein-protein interaction by in vitro evolution.
George Thom, Alexis C Cockroft, Andrew G Buchanan, Cathy Joberty Candotti, E Suzanne Cohen, Ralph R Minter

Proc Natl Acad Sci U S A· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning and characterization of Xenopus beta2-microglobulin.
Rebecca Stewart, Yuko Ohta, Ralph R Minter, Terry Gibbons, Trudy L Horton

Dev Comp Immunol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Kevin P Baker, Bryan M Edwards, Sarah H Main, Gil H Choi, Ruth E Wager, Ralph R Minter

Arthritis Rheum· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis